Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer
Authors:
- 1 March 2021
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 28 (8) , 2331-2341
Abstract
Improved insight into the molecular mechanisms of triple-negative breast cancer (TNBC) is required to predict prognosis and develop a new therapeutic strategy for targeted genes. The aim of this study was to identify genes significantly associated with TNBC and further analyze their prognostic significance. The Cancer Genome Atlas (TCGA) TNBC database and gene expression profiles of GSE76275 from Gene Expression Omnibus (GEO) were used to explore differentially co-expressed genes in TNBC compared with those in normal tissues and non-TNBC breast cancer tissues. Differential gene expression and weighted gene co-expression network analyses identified 24 differentially co-expressed genes. Functional annotation suggested that these genes were primarily enriched in processes such as metabolism, membrane, and protein binding. The protein-protein interaction (PPI) network further identified ten hub genes, five of which (MAPT, CBS, SOX11, IL6ST, and MEX3A) were confirmed to be differentially expressed in an independent dataset (GSE38959). Moreover, CBS and MEX3A expression was upregulated, whereas IL6ST expression was downregulated in TNBC tissues compared to that in other breast cancer subtypes. Furthermore, lower expression of IL6ST was associated with worse overall survival in patients with TNBC. Thus, IL6ST might play an important role in TNBC progression and could serve as a tumor suppressor gene for diagnosis and treatment.Keywords
Funding Information
- Youth Innovation of Inner Mongolia Medical University (YKD2020QNCX021)
This publication has 23 references indexed in Scilit:
- Introduction to the Gene Expression Analysis2016
- Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumorsMolecular Cytogenetics, 2016
- Anti-proliferative actions of a synthetic REV-ERBα/β agonist in breast cancer cellsBiochemical Pharmacology, 2015
- Cdc20 and securin overexpression predict short-term breast cancer survivalBritish Journal of Cancer, 2014
- Plasma homocysteine levels and genetic polymorphisms in folate metablism are associated with breast cancer risk in chinese womenHereditary Cancer in Clinical Practice, 2014
- Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cellsMolecular Medicine Reports, 2012
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Refinement of breast cancer classification by molecular characterization of histological special typesThe Journal of Pathology, 2008
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Molecular portraits of human breast tumoursNature, 2000